Cure My Disease

Don't miss your cure!

 Log in / Sign up

Urine test could reveal how HPV vaccine fights the virus

NCT ID NCT07407569

Recruiting now Knowledge-focused Sponsor: Universiteit Antwerpen Source: ClinicalTrials.gov ↗

First seen Feb 19, 2026 · Last updated May 16, 2026 · Updated 11 times

Summary

This study looks at how the Gardasil-9 HPV vaccine affects the virus in women who already have HPV16. About 50 women aged 18-45 will get two doses of the vaccine. Researchers will use urine samples to check if the vaccine reduces the virus's ability to infect cells and to track antibody levels over 24 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antwerp University Hospital

    RECRUITING

    Antwerp, Wilrijk, 2650, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Ghent

    RECRUITING

    Ghent, 9000, Belgium

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Leuven

    RECRUITING

    Leuven, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 HUMAN PAPILLOMA VIRUS INFECTION TYPE 16